publication . Article . Other literature type . 2019

Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.

Daly Avendano; Daly Avendano; Pascal A. T. Baltzer; Katja Pinker; Katja Pinker; Doris Leithner; Danny F. Martinez; Paola Clauser; Panagiotis Kapetas; Sunitha B. Thakur; ...
Open Access English
  • Published: 01 Dec 2019 Journal: Breast Cancer Research : BCR, volume 21 (issn: 1465-5411, eissn: 1465-542X, Copyright policy)
  • Publisher: BioMed Central
Abstract
<jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>Available data proving the value of DWI for breast cancer diagnosis is mainly for enhancing masses; DWI may be less sensitive and specific in non-mass enhancement (NME) lesions. The objective of this study was to assess the diagnostic accuracy of DWI using different ROI measurement approaches and ADC metrics in breast lesions presenting as NME lesions on dynamic contrast-enhanced (DCE) MRI.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>In this retrospective study, 95 patients who underwent multiparametric MRI with DCE and DWI from September 2007 to J...
Subjects
free text keywords: Research Article, Breast cancer, Magnetic resonance imaging, Non-mass enhancement, Diffusion-weighted imaging, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Cancer Research, Oncology, Effective diffusion coefficient, Nuclear medicine, business.industry, business, medicine.diagnostic_test, medicine, Dynamic contrast-enhanced MRI, Histopathology, medicine.medical_specialty, Diffusion MRI, Concordance correlation coefficient, Receiver operating characteristic, medicine.disease
Funded by
EC| MURAB
Project
MURAB
MRI and Ultrasound Robotic Assisted Biopsy
  • Funder: European Commission (EC)
  • Project Code: 688188
  • Funding stream: H2020 | RIA
,
NIH| MOUSE GENETICS
Project
  • Funder: National Institutes of Health (NIH)
  • Project Code: 2P30CA008748-43
  • Funding stream: NATIONAL CANCER INSTITUTE
,
EC| CANCER SCAN
Project
CANCER SCAN
A Body Scan for Cancer Detection using Quantum Technology
  • Funder: European Commission (EC)
  • Project Code: 828978
  • Funding stream: H2020 | RIA
,
EC| HYPMED
Project
HYPMED
Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer
  • Funder: European Commission (EC)
  • Project Code: 667211
  • Funding stream: H2020 | RIA
Communities
FET H2020FET OPEN: FET-Open Challenging Current Thinking
FET H2020FET OPEN: A Body Scan for Cancer Detection using Quantum Technology
35 references, page 1 of 3

Gutierrez, RL, DeMartini, WB, Eby, PR, Kurland, BF, Peacock, S, Lehman, CD. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. AJR Am J Roentgenol. 2009; 193 (4): 994-1000 [OpenAIRE] [PubMed] [DOI]

Benndorf, M, Baltzer, PAT, Kaiser, WA. Assessing the degree of collinearity among the lesion features of the MRI BI-RADS lexicon. Eur J Radiol. 2011; 80 (3): e322-e324 [OpenAIRE] [PubMed] [DOI]

Illan, IA, Ramirez, J, Gorriz, JM. Automated detection and segmentation of nonmass-enhancing breast tumors with dynamic contrast-enhanced magnetic resonance imaging. Contrast Media Mol Imaging. 2018; 2018: 5308517 [OpenAIRE] [PubMed] [DOI]

Marino, Maria Adele, Clauser, Paola, Woitek, Ramona, Wengert, Georg J., Kapetas, Panagiotis, Bernathova, Maria, Pinker-Domenig, Katja, Helbich, Thomas H., Preidler, Klaus, Baltzer, Pascal A. T.. A simple scoring system for breast MRI interpretation: does it compensate for reader experience?. European Radiology. 2015; 26 (8): 2529-2537 [OpenAIRE] [PubMed] [DOI]

Helbich, TH. Contrast-enhanced magnetic resonance imaging of the breast. Eur J Radiol. 2000; 34 (3): 208-219 [PubMed] [DOI]

Pinker, K, Bickel, H, Helbich, TH. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the “Breast Imaging Reporting and Data System” for multiparametric 3-T imaging of breast lesions. Eur Radiol. 2013; 23 (7): 1791-1802 [OpenAIRE] [PubMed] [DOI]

Spick, C, Baltzer, PAT. Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis. Radiology.. 2014; 273 (2): 401-409 [OpenAIRE] [PubMed] [DOI]

Spick, C, Pinker-Domenig, K, Rudas, M, Helbich, TH, Baltzer, PA. MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies. Eur Radiol. 2014; 24 (6): 1204-1210 [OpenAIRE] [PubMed] [DOI]

Kuhl, CK. Current status of breast MR imaging. Part 2. Clinical applications. Radiology.. 2007; 244 (3): 672-691 [OpenAIRE] [PubMed] [DOI]

Baltzer, PAT, Kapetas, P, Marino, MA, Clauser, P. New diagnostic tools for breast cancer. Memo.. 2017; 10 (3): 175-180 [OpenAIRE] [PubMed] [DOI]

Marini, C, Iacconi, C, Giannelli, M, Cilotti, A, Moretti, M, Bartolozzi, C. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol. 2007; 17 (10): 2646-2655 [OpenAIRE] [PubMed] [DOI]

Guo, Y, Cai, Y-Q, Cai, Z-L. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging JMRI.. 2002; 16 (2): 172-178 [OpenAIRE] [PubMed] [DOI]

Rahbar, H, Zhang, Z, Chenevert, TL. Utility of diffusion-weighted imaging to decrease unnecessary biopsies prompted by breast MRI: a trial of the ECOG-ACRIN cancer research group (A6702). Clin Cancer Res Off J Am Assoc Cancer Res. 2019; 25 (6): 1756-1765 [DOI]

Gulani, V, Calamante, F, Shellock, FG, Kanal, E, Reeder, SB. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017; 16 (7): 564-570 [OpenAIRE] [PubMed] [DOI]

Leithner, Doris, Moy, Linda, Morris, Elizabeth A, Marino, Maria A, Helbich, Thomas H, Pinker, Katja. Abbreviated MRI of the Breast: Does It Provide Value?. Journal of Magnetic Resonance Imaging. 2018; 49 (7): e85-e100 [OpenAIRE] [PubMed] [DOI]

35 references, page 1 of 3
Any information missing or wrong?Report an Issue